BCL2L2 and colorectal carcinoma: Qu et al. concorded with the latter hypothesis of miR-195 as promoter of CRC chemosensitivity; in particular, they investigated the relation between the suppression of BCL2-like 2 (BCL2L2) by miR-195 and the sensitivity to DOXO [35].